Know Cancer

or
forgot password
  • cancer clinical trials in grand junction, CO

  • Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Head and Neck Cancer
    Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Prostate Cancer
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Bladder Cancer
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Prostate Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Brain and Central Nervous System Tumors
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lung Cancer
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Saint Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502-1628
    Head and Neck Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Leukemia
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Esophageal Cancer, Gastric Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Anastrozole & ZD1839 Compared With Fulvestrant & ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Creatine in Treating Patients With Cancer-Associated Weight Loss
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Prostate Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Colorectal Cancer
    Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Colorectal Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Mantle Cell Lymphoma
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Multiple Myeloma and Plasma Cell Neoplasm
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Metastatic Cancer, Prostate Cancer
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Chronic Myeloproliferative Disorders
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Head and Neck Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Prostate Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Prostate Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Leukemia
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Neuroendocrine Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Lung Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Endometrial Cancer, Fatigue, Neurotoxicity
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Leukemia
    S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Saint Mary's Hospital and Regional Medical Center
    Grand Junction, Colorado 81502
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Liver Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
    Grand Junction, Colorado 81502
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer